Filters close
Newswise: UC San Diego Health First in Region to Provide Novel Therapy for Melanoma
Released: 4-Jun-2024 1:05 PM EDT
UC San Diego Health First in Region to Provide Novel Therapy for Melanoma
UC San Diego Health

Breakthrough one-time cancer treatment option for select patients with metastatic melanoma and solid tumors now offered at UC San Diego Health.

Newswise: Molecular switch linked to lineage plasticity, therapy resistance
Released: 4-Jun-2024 12:05 PM EDT
Molecular switch linked to lineage plasticity, therapy resistance
UT Southwestern Medical Center

Two genes working in tandem play a critical role in shaping the identity and behavior of prostate cancer cells and their response to treatment, UT Southwestern Medical Center researchers report.

Released: 4-Jun-2024 11:05 AM EDT
Comparative Study on Dual vs Single Cardioversion for Atrial Fibrillation in Obese Patients
Ochsner Health

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial fibrillation and obesity.

Newswise: 1920_deep-brain-stimulation-cedars-sinai.jpg?10000
Released: 4-Jun-2024 11:05 AM EDT
Can Deep Brain Stimulation Help More Patients?
Cedars-Sinai

Deep brain stimulation procedures use electrical pulses to disrupt tiny portions of the brain and halt epileptic seizures or disease-related tremor. The therapy is invaluable, but the basic technology has not advanced in decades.

Newswise: Wistar Scientists Develop Novel Antibody Treatment for Kidney Cancer
Released: 4-Jun-2024 11:05 AM EDT
Wistar Scientists Develop Novel Antibody Treatment for Kidney Cancer
Wistar Institute

Wistar scientists have built upon BTE technology to develop new and improved recombinant and synthetic DNA versions of therapeutic antibodies that target CA9, called Persistent Multivalent T Cell Engager (CA9-PMTE), that shows promise in pre-clinical models as a potent, long-lasting treatment against ccRCC.

3-Jun-2024 1:00 PM EDT
New RadiologyInfo.org Series Helps Patients Understand Their Exam Reports
Radiological Society of North America (RSNA)

RadiologyInfo.org, a leading source of medical imaging information for the general public, has introduced a new series of articles and videos to help patients understand their radiology exam reports.

   
Newswise: steven_frank.jpg.resize.405.575.high.jpg
3-Jun-2024 8:05 AM EDT
ASCO: Proton therapy demonstrates advantages in Phase III head and neck cancer trial
University of Texas MD Anderson Cancer Center

According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved similar clinical outcomes and offered significant patient benefits when compared to traditional intensity modulated radiation therapy (IMRT) as part of chemoradiation treatment for patients with oropharyngeal (head and neck) cancer.

Released: 4-Jun-2024 10:20 AM EDT
Uncovering mysteries of the developing brain
Michigan Medicine - University of Michigan

Thousands of American teens and their families are helping scientists learn more about the growth and development of the brain and its impacts on behavior, mental health and much more, through a national study called ABCD that also includes thousands of other young people nationwide.

Released: 4-Jun-2024 10:05 AM EDT
Select Medical Gifts $5 Million Over Five Years to Harrisburg University
Harrisburg University of Science and Technology

The Select Medical Institute of Physical Therapy and Movement at Harrisburg University will build pathways to expand the physical therapy workforce while providing career advancement opportunities for students and continuing education for professionals.

     
Newswise: Dermatologic conditions – even sunburn – can present differently in people of color
Released: 4-Jun-2024 9:05 AM EDT
Dermatologic conditions – even sunburn – can present differently in people of color
University of California, Los Angeles (UCLA), Health Sciences

UCLA Health dermatologist Caroline Opene, MD treats patients of all skin tones, but as director of the UCLA Health Skin of Color clinic, she has special expertise in treating skin of color. Below are some of the topics she is often asked about.

Newswise: Rensselaer Researcher Sheds New Light on Circadian Rhythms
Released: 4-Jun-2024 9:05 AM EDT
Rensselaer Researcher Sheds New Light on Circadian Rhythms
Rensselaer Polytechnic Institute (RPI)

Circadian clocks, which drive circadian rhythms, are entwined with many essential systems in living things including plants, fungi, insects, and even humans. Because of this, disruptions to our circadian clocks are linked to higher disease rates in humans, including certain cancers and autoimmune diseases.

   
31-May-2024 9:05 AM EDT
Stopping a spreading fire: identifying connections between adverse childhood events and substance use disorders
Perelman School of Medicine at the University of Pennsylvania

Physical and sexual abuse, having parents who misuse substances, and witnessing violent crime are tragic events that don’t remain locked in a single point in time. Rather, they are termed adverse childhood experiences (ACEs) and 64 percent of American adults who participated in a recent survey reported experiencing at least one ACE prior to turning 18 years old.

   
Newswise: U.S. Drug-related Infant Deaths More than Doubled from 2018 to 2022
Released: 4-Jun-2024 8:30 AM EDT
U.S. Drug-related Infant Deaths More than Doubled from 2018 to 2022
Florida Atlantic University

Drug-involved infant deaths more than doubled (120% increase) from 2018 to 2022, with the greatest proportion of deaths in 2021 (25.8%). The most prevalent underlying causes of death included assault (homicide) by drugs, medicaments and biological substances (35.6%).

Released: 4-Jun-2024 8:05 AM EDT
AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024
AbelZeta Pharma, Inc.

CAR031 study at 9.03-mo median follow up achieves disease control rate (DCR) of 91.3% and objective response rate (ORR) of 56.5% for patients across all dose levels (DLs) and ORR of 75.0% at DL4

Released: 4-Jun-2024 7:05 AM EDT
Rutgers Research Bridging Gaps in Alzheimer’s Risk Among South Asian Populations
Rutgers University-New Brunswick

Researchers at the Krieger Klein Alzheimer’s Research Center at Rutgers Brain Health Institute are launching a pioneering study to better understand the characteristics that place South Asian populations at heightened risk for Alzheimer’s disease.

Newswise: 5-Minute Test Leads to Better Care for People with Dementia in the Primary Care Setting
3-Jun-2024 10:05 AM EDT
5-Minute Test Leads to Better Care for People with Dementia in the Primary Care Setting
Albert Einstein College of Medicine and Montefiore Health System

The underdiagnosis of dementia, especially among Black and Hispanic patients, is a long-standing challenge in medicine.

Released: 3-Jun-2024 7:05 PM EDT
Stepping Up Summer Fun: the Cancer Research – Scholarship and Training Experience in Population Sciences (C‐STEPS) Program
University of New Mexico Comprehensive Cancer Center

Over the last two decades, strides in cancer prevention, earlier detection, and novel treatments have reduced overall cancer mortality; however, cancer health disparities (CHD) persist among demographically diverse and intersecting populations.

Not for public release

This news release is embargoed until 3-Jun-2024 5:00 PM EDT Released to reporters: 28-May-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Jun-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 3-Jun-2024 5:00 PM EDT Released to reporters: 28-May-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Jun-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.



close
0.14583